Cargando…
Recurrent Stroke Due to Antiphospholipid Syndrome Remitted by Immunotherapy, Not by Anticoagulation Therapy: A Case Report and Literature Review
Autores principales: | Park, Jin-Mo, Eah, Kyung Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472235/ https://www.ncbi.nlm.nih.gov/pubmed/31007453 http://dx.doi.org/10.4103/aian.AIAN_433_18 |
Ejemplares similares
-
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022) -
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment
por: Cohen, Hannah, et al.
Publicado: (2017) -
Antiphospholipid syndrome is an important modifiable risk factor of stroke in the young
por: Khan, Sujoy
Publicado: (2015) -
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022) -
Arterial ischemic stroke in a patient with co-existence of antiphospholipid syndrome and ulcerative colitis
por: Park, Soonchan, et al.
Publicado: (2022)